The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis

被引：0
|
作者：
Yang, Xu
Wang, Dongxu
Lin, Jianzhen
Xiong, Jianping
Long, Junyu
Bai, Yi
Bian, Jin
Huang, Hanchun
Yang, Xiaobo
Mao, Yilei
Sang, Xinting
Zhao, Haitao
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Peking Union Med, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4992
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
    Yee-Ming Melody Cheung
    Wei Wang
    Bradley McGregor
    Ole-Petter Riksfjord Hamnvik
    Cancer Immunology, Immunotherapy, 2022, 71 : 1795 - 1812
  • [32] Associations Between Immune-Related Venous Thromboembolism and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Li, Huimin
    Li, Hong
    Tang, Le
    Niu, Haiwen
    He, Lili
    Luo, Qin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [33] Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
    Cheung, Yee-Ming Melody
    Wang, Wei
    McGregor, Bradley
    Hamnvik, Ole-Petter Riksfjord
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 1795 - 1812
  • [34] Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis
    Su, Qiang
    Zhang, Xiao-chen
    Zhang, Chen-guang
    Hou, Yan-li
    Yao, Yu-xia
    Cao, Bang-wei
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [35] USE OF IMMUNE CHECKPOINT INHIBITORS AND RISK OF IMMUNE-RELATED ADVERSE EVENTS AMONG PATIENTS WITH ADVANCED MELANOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Chang, C. Y.
    Park, H.
    Lo-Ciganic, W.
    VALUE IN HEALTH, 2019, 22 : S89 - S89
  • [36] Association between immune-related adverse events and prognosis after immune checkpoint inhibitor in hepatocellular carcinoma: A meta-analysis and systematic review.
    Hwang, Soo Young
    Rezaee-Zavareh, Mohammad Saeid
    Attia, Abdelrahman M.
    Kaymen, Emily
    Tran, Nguyen H.
    Abou-Alfa, Ghassan K.
    Singal, Amit
    Yang, Ju Dong
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 566 - 566
  • [37] Use of immune checkpoint inhibitors and risk of immune-related adverse events among patients with advanced melanoma: A systematic review and network meta-analysis
    Chang, Ching-Yuan
    Wang, Ching-Yu
    Park, Haesuk
    Lo-Ciganic, Wei-Hsuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 472 - 473
  • [38] Immune-related serious adverse events with immune checkpoint inhibitors: systematic review and network meta-analysis (vol 80, pg 677, 2024)
    Oliveira, Clara
    Mainoli, Beatrice
    Duarte, Goncalo S.
    Machado, Tiago
    Tinoco, Rita G.
    Esperanca-Martins, Miguel
    Ferreira, Joaquim J.
    Costa, Joao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (10) : 1597 - 1598
  • [39] Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhang, Wei
    Tan, Yifei
    Li, Yuquan
    Liu, Jiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Prognostic relevance of immune-related adverse events in lung cancer patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
    Huang, Yuchen
    Ma, Wananqi
    Wu, Dongsheng
    Lyu, Mengyuan
    Zheng, Quan
    Wang, Tengyong
    Zhou, Jian
    Liu, Chengwu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07)
12345